This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hisamitsu Pharmaceutical Co., Inc.
Drug Names(s): ropinirole hydrochloride transdermal patch
Description: HP-3000 is a transdermal patch formulation of the dopamine D2/D3 receptor agonist ropinirole hydrochloride.
Additional information available to subscribers only: